CJC-1295 / Ipamorelin

Build Muscle

Choose a treatment option

Subcutaneous Injection

Precise, reliable dosing; ideal for peptides that can't survive digestion

From $249/mo

CJC-1295 and Ipamorelin are synthetic peptides that act synergistically to stimulate natural growth hormone (GH) release from the pituitary gland. CJC-1295 is a long-acting Growth Hormone Releasing Hormone (GHRH) analog, while Ipamorelin is a selective Growth Hormone Secretagogue (GHS) that mimics ghrelin’s GH-stimulating effects. Together, they promote physiologic GH pulsatility rather than direct hormone replacement.

Check eligibility

These peptides are compounded and not FDA-approved to diagnose, treat, cure, or prevent any disease, or for anti-aging or performance uses.

Why it works

Key benefits

Support for lean muscle growth and body composition

Enhanced recovery, repair, and cellular regeneration

Improved sleep quality and energy

Possible assistance with fat metabolism and skin elasticity

Observed in limited clinical and pre-clinical data. These effects are based on small studies and clinical observation; human outcome data remain limited.

Mechanism

How it works

CJC-1295 binds to GHRH receptors in the pituitary, increasing GH synthesis and release. Its DAC modification (Drug Affinity Complex) extends its half-life for prolonged activity. Ipamorelin binds to ghrelin (GHSR) receptors, amplifying GH release without significantly affecting appetite or cortisol. When combined, the peptides act on complementary pathways to increase circulating GH and IGF-1 levels, which may influence recovery, metabolism, and sleep quality.

Frequently asked questions

FAQs

Gradual effects, often starting with deeper sleep and improved recovery within 2–4 weeks. Changes in energy, strength, or body composition, when present, develop more gradually (6–12 weeks).

Most individuals tolerate therapy well. Potential effects include: Temporary injection-site redness or irritation Mild water retention, tingling, or increased hunger Rare: headache or lightheadedness

Interested in CJC-1295 / Ipamorelin?

Take a short assessment and a licensed provider will review if this treatment is right for you.

Check eligibility

Clinical Guidance Disclaimer

The information provided in this document is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. It should never replace sound clinical judgment or personalized advice of a qualified healthcare professional. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment protocol. Never disregard professional medical advice or delay in seeking it because of something you have read in these materials.

Liability & Indemnification

By utilizing this information, the user acknowledges and agrees that REBL and its affiliates, providers, and staff are not liable for any direct, indirect, or consequential damages resulting from the use or misuse of the information provided herein. Any reliance on the materials contained in this document is solely at the user's own risk.

Proprietary Rights & Use Restrictions

This document and its contents are the proprietary property of REBL. Unauthorized use, duplication, reproduction, or distribution of these materials—in whole or in part—without express written consent is strictly prohibited.